Largest pharmaceutical companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 pharmaceutical companies ranked by total liabilities, at NOK 1.33T, ahead of Pfizer (NOK 1.18T) and Johnson & Johnson (NOK 1.14T). Figures as of 18 Nov 2026, 19:01 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbVieNOK 1.33T
- Median
- NOK 20.2B
- Combined market value
- NOK 49.29T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | NOK 1.33T | NOK 4.92T | NOK 2,783.07 | 2.00% down | 26% up | ||
| 2 | PfizerPFE · Health Care | NOK 1.18T | NOK 1.56T | NOK 272.90 | 1.16% down | 14% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | NOK 1.14T | NOK 6.42T | NOK 2,664.80 | 1.41% down | 38% up | ||
| 4 | Eli LillyLLY · Health Care | NOK 833.5B | NOK 12.03T | NOK 13,500.50 | 1.66% down | 35% up | ||
| 5 | Merck & CoMRK · Health Care | NOK 816.6B | NOK 3.3T | NOK 1,339.19 | 3.68% down | 51% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | NOK 693.7B | NOK 1.19T | NOK 582.26 | 2.14% down | 34% up | ||
| 7 | AstraZenecaAZN · Health Care | NOK 633.8B | NOK 2.7T | NOK 1,739.33 | 1.60% down | 2% up | ||
| 8 | NovartisNVS · Health Care | NOK 624.5B | NOK 2.85T | NOK 1,510.89 | 2.10% down | 25% up | ||
| 9 | SanofiSNY · Health Care | NOK 592.8B | NOK 1.1T | NOK 458.32 | 0.57% down | 4% down | ||
| 10 | GSKGSK · Health Care | NOK 581.4B | NOK 947.4B | NOK 472.63 | 1.03% down | 6% up | ||
| 11 | Novo NordiskNVO · Health Care | NOK 502.1B | NOK 1.69T | NOK 383.17 | 2.92% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | NOK 490.8B | NOK 661.8B | NOK 207.15 | 1.29% down | 54% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | NOK 329.2B | NOK 1.76T | NOK 1,013.53 | 0.19% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | NOK 318.4B | NOK 476.2B | NOK 408.09 | 1.27% down | 74% up | ||
| 15 | ViatrisVTRS · Health Care | NOK 218B | NOK 230.3B | NOK 200.84 | 1.27% up | 96% up | ||
| 16 | GrifolsGRFS · Health Care | NOK 130.3B | NOK 55.8B | NOK 81.95 | 2.09% down | 1% up | ||
| 17 | ZoetisZTS · Health Care | NOK 117.7B | NOK 335.9B | NOK 826.75 | 2.12% up | 29% down | ||
| 18 | Royalty PharmaRPRX · Health Care | NOK 96.1B | NOK 387B | NOK 673.13 | 1.06% up | 78% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | NOK 90.2B | NOK 951.2B | NOK 9,195.30 | 1.00% down | 36% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | NOK 71.2B | NOK 153.7B | NOK 2,394.66 | 2.58% up | 37% up | ||
| 21 | GenmabGMAB · Health Care | NOK 68.1B | NOK 307.8B | NOK 499.25 | 0.92% down | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | NOK 67.7B | NOK 1.32T | NOK 5,225.54 | 0.87% up | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | NOK 66.1B | NOK 130.3B | NOK 260.78 | 4.02% up | 20% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | NOK 40.5B | NOK 195.4B | NOK 1,458.91 | 3.88% down | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | NOK 37.1B | NOK 448.5B | NOK 3,926.31 | 2.03% down | 17% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | NOK 35.6B | NOK 74.5B | NOK 213.74 | 4.36% up | 83% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | NOK 30.1B | NOK 48.9B | NOK 584.81 | 0.10% down | 20% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | NOK 29.4B | NOK 45.2B | NOK 271.15 | 3.71% up | 64% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | NOK 29.2B | NOK 147.5B | NOK 757.22 | 1.67% up | 17% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | NOK 20.5B | NOK 121.5B | NOK 145.71 | 1.59% up | 5% up | ||
| 31 | CytokineticsCYTK · Health Care | NOK 20.2B | NOK 69.5B | NOK 498.67 | 0.45% down | 20% down | ||
| 32 | Ascendis PharmaASND · Health Care | NOK 15.8B | NOK 172.3B | NOK 2,626.69 | 0.13% down | 28% up | ||
| 33 | InsmedINSM · Health Care | NOK 14.8B | NOK 256.3B | NOK 1,168.17 | 1.15% down | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | NOK 14.6B | NOK 114B | NOK 588.57 | 3.73% up | 11% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | NOK 8.6B | NOK 59.5B | NOK 420.65 | 0.90% up | 10% up | ||
| 36 | United TherapeuticsUTHR · Health Care | NOK 7.6B | NOK 240.3B | NOK 5,643.04 | 0.38% down | 23% up | ||
| 37 | Legend BiotechLEGN · Health Care | NOK 7.1B | NOK 30.5B | NOK 157.30 | 0.68% up | 42% down | ||
| 38 | AlkermesALKS · Health Care | NOK 6.5B | NOK 76.4B | NOK 454.69 | 3.16% up | 58% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | NOK 6.4B | NOK 91.4B | NOK 3,935.13 | 3.84% down | 24% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | NOK 5.8B | NOK 68.7B | NOK 1,305.63 | 0.97% down | 7% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | NOK 5.3B | NOK 58.6B | NOK 2,927.86 | 2.76% up | 43% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | NOK 5.1B | NOK 58.3B | NOK 893.67 | 0.22% up | 31% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | NOK 4.8B | NOK 47.6B | NOK 495.47 | 0.02% down | 44% up | ||
| 44 | Roivant SciencesROIV · Health Care | NOK 4B | NOK 270.9B | NOK 373.86 | 0.41% down | 90% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | NOK 4B | NOK 96.9B | NOK 641.03 | 5.41% up | 107% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | NOK 2.9B | NOK 47.2B | NOK 271.01 | 0.34% up | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | NOK 2B | NOK 81.2B | NOK 1,171.80 | 3.62% up | 13% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 1.9B | NOK 72.5B | NOK 922.76 | 0.04% up | 126% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | NOK 1.8B | NOK 72.2B | NOK 659.90 | 2.89% down | 8% down | ||
| 50 | ABIVAXABVX · Health Care | NOK 1.4B | NOK 71.2B | NOK 813.12 | 2.13% up | 27% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | NOK 1B | NOK 38.2B | NOK 279.40 | 1.94% down | 169% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | NOK 895.3M | NOK 81.7B | NOK 102.17 | 1.27% down | 36% down | ||
| 53 | ErascaERAS · Health Care | NOK 688.4M | NOK 45.6B | NOK 129.86 | 3.60% down | 403% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | NOK 606.6M | NOK 89.1B | NOK 938.57 | 3.17% up | 286% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | NOK 579.7M | NOK 83.5B | NOK 2,986.97 | 0.96% up | 61% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | NOK 518.7M | NOK 79.7B | NOK 1,220.66 | 0.96% up | 46% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | NOK 363.9M | NOK 47.5B | NOK 844.35 | 0.10% up | 113% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | NOK 294.3M | NOK 44.2B | NOK 404.02 | 0.90% down | 88% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | NOK 161.8M | NOK 63.1B | NOK 931.00 | 0.33% down | 241% up | ||
| 60 | Belite BioBLTE · Health Care | NOK 97.7M | NOK 62.1B | NOK 1,529.37 | 0.01% down | 31% up | ||
| 61 | VeradermicsMANE · Health Care | NOK 88.8M | NOK 51B | NOK 1,209.62 | 0.72% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6979 NOK).
Questions and answers
Which pharmaceutical companies rank first by total liabilities?
AbbVie (NOK 1.33T), Pfizer (NOK 1.18T) and Johnson & Johnson (NOK 1.14T) are the top three of the 61 pharmaceutical companies ranked by total liabilities as of 18 Nov 2026, 19:01 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by total liabilities have a combined market value of NOK 49.29T as of 18 Nov 2026, 19:01 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.